"Adjusted costs of Phase II trials $96 - 38 million. #Novartis sales for Gleevec in 2012 $4.675 billion, $390 million per month" @jamie_love
12:46 PM - 17 Apr 2013
0 replies
2 retweets
0 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.